Global defibrillators market is estimated to be valued at USD 12.70 Bn in 2024 and is expected to exhibit a CAGR of 6.8% during the forecast period (2024-2031). Defibrillators are medical devices that deliver an electric shock to the heart in order to induce rhythmic contractions in case of cardiac arrhythmias like ventricular fibrillation. The defibrillator market has seen steady growth over the years owing to the rising prevalence of cardiovascular diseases worldwide. Advancements in technology have led to the development of implantable and automated external defibrillators that can detect arrhythmias and provide treatment without any intervention. Growing healthcare expenditures along with government policies promoting public access defibrillators are some factors driving the demand for these life-saving devices.

Market Dynamics:

The global defibrillators market is projected to witness significant growth over the forecast period owing to the rising geriatric population, growing prevalence of target diseases like sudden cardiac arrest, and technological advancements. However, high cost of advanced defibrillators is a major challenge for market players. Opportunities lie in developing economies due to undertreatment of cardiovascular diseases. Growing healthcare investments by governments offers potential growth prospects. Key players are developing automated external defibrillators for public access use to reduce out-of-hospital cardiac arrests. Miniaturization of implantable devices without compromise on performance will further fuel the market growth.

Key Features of the Study:

• This report provides an in-depth analysis of the global defibrillators market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global defibrillators market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Koninklijke Philips N.V., Metrax GmbH, Medtronic, Mindray Medical International Limited, Boston Scientific Corporation, GE Healthcare, Nihon Kohden, Abbott, BIOTRONIK, Stryker, LivaNova PLC, Asahi Kasei Corporation, MicroPort Scientific Corporation, Schiller AG, and Bexen Cardio
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global defibrillators market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global defibrillators market.

Market Segmentation

• Product Type:
  • Implantable Cardioverter Defibrillators 
    • Single chamber
    • Dual chamber
    • Biventricular
    • Subcutaneous
  • External Defibrillators 
    • Manual External Defibrillators
    • Automated External Defibrillators
    • Wearable Cardioverter Defibrillators
• End User:
  • Hospitals
  • Homecare Settings
  • Public Access Settings
  • Pre-hospital Care Settings
  • Others
• Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Koninklijke Philips N.V.
  • Metrax GmbH
  • Medtronic
  • Mindray Medical International Limited
  • Boston Scientific Corporation
  • GE Healthcare
  • Nihon Kohden
  • Abbott
  • BIOTRONIK
  • Stryker
  • LivaNova PLC
  • Asahi Kasei Corporation
  • MicroPort Scientific Corporation
  • Schiller AG
  • Bexen Cardio